Work

Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States – a retrospective claims study

Year: 2023
Type: article
Study design: Observational Study
Abstract: Objective: To describe post-traumatic stress disorder (PTSD)-related symptoms and frequent psychiatric comorbidities, treatments received, healthcare resource utilization (HRU), and healthcare costs pre-and post-PTSD diagnosis among adults in the United States.Methods: Adults with PTSD who received a PTSD-related pharmacological treatment (selective serotonin reuptake inhibitor [SSRI], serotonin-norepinephrine reuptake inhibitor [SNRI], atypical antipsychotic [AA]) within 24 months of the first observed PTSD diagnosis (index date) were identified using MarketScan Commercial Database (2015)(2016)(2017)(2018)(2019)(2020).Study outcomes were assessed during the 6month pre-diagnosis and 24-month post-diagnosis periods.Subgroup analyses included patients treated or not treated with AAs post-PTSD diagnosis.Results: Of the overall patients (N ¼ 26,306; mean age at diagnosis 39.5 years; 73.3% female), 85.9% had PTSD-related symptoms and frequent psychiatric comorbidities during the 6 months pre-diagnosis.Patients treated with AAs post-PTSD diagnosis (N ¼ 9,298) tended to have higher rates of PTSD-related symptoms and comorbidities at diagnosis than those not treated with AAs (N ¼ 7,011).Following diagnosis, the most commonly observed first-line treatments were SSRI (67.4%),AA (23.4%), and SNRI (22.6%).The rate of PTSD-related symptoms and comorbidities, psychotherapy and pharmacological treatments received, HRU, and healthcare costs increased during the 6 months post-diagnosis relative to the 6 months pre-diagnosis and then declined over time during the 24 months post-diagnosis.Conclusions: The PTSD diagnosis was associated with increased rates of symptoms and frequent psychiatric comorbidities, psychotherapy and pharmacological treatments received, HRU, and healthcare costs, pointing to increased patient monitoring.Within 6 to 12 months after the PTSD diagnosis, these outcomes tended to reduce, perhaps as patients were obtaining targeted and effective care.
Language: English
Field: Psychology
Open Access status: hybrid
OpenAlex ID: W4387515865
FWCI: 1.507
Cites: 36
Cited by: 8
Related to: 10